Why It Matters
Leveraging AI to forecast clinical trial outcomes can help biomedical stakeholders gain better insight into the drug and device approval process.Read more
Manufacturers are remaking their business propositions, aided by AI, machine learning, augmented reality, and the ‘industrial internet of things.’
As consumers and workers assert ownership of their data, new cooperatives could help them band together to use it.
Using artificial intelligence to enhance data on clinical trial outcomes can help biomedical firms, investors, and — ultimately — patients.